Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

brontictuzumab

A humanized monoclonal antibody directed against the Notch-1 receptor with potential antineoplastic activity. Upon administration, brontictuzumab binds to Notch-1 on the cell surface, thereby inhibiting Notch-mediated signaling and tumor cell proliferation. Notch 1, a type 1 transmembrane protein belonging to the Notch family, functions as a receptor for membrane bound ligands and has various roles during development; dysregulated Notch signaling is associated with increased cell growth and chemoresistance in cancers.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:anti-Notch1 monoclonal antibody OMP-52M51
immunoglobulin G2-lambda, anti-(homo sapiens Notch1 (Notch 1, translocation-associated Notch-1, TAN-1,Tan1)), humanized monoclonal antibody
Code name:OMP-52M51
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search